3rd International Caparica Conference on Leishmaniasis 2022
24th – 26th October 2022 | Caparica | Portugal
Dear Colleagues and friends
On behalf of the organizing committee, we are delighted to welcome you to Caparica (Lisbon, Portugal), for the 3rd International Caparica Congress on Leishmaniasis 20202 (LEISHMANIASIS2022).
This conference intends to gather researchers working in areas related to Leishmaniasis, from treatment to prevention. In fact, as leishmaniasis is slowly but constantly, increasing worldwide, this conference is addressed to show the latest research trends in this area. The idea is to push forward the battle against this persistent disease.
The conference will promote networking sessions to link the different skills of participants so international teams will be created to apply to funding at the international level.
We are confident that you will appreciate the breadth and quality of the scientific program and the city of Caparica.
We look forward to seeing you in 2022 in Portugal.
J. L. Capelo
On behalf of the organizing and scientific committee
Shaden Kamhawi, PhD
Affiliation: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville (USA)
Title: Leishmania transmission by sand flies implicate parasite, vector and host factors as drivers of disease establishment.
Christian Bogdan, M.D.
Affiliation: Director of the Institute of Clinical Microbiology; Immunology and Hygiene University Hospital of Erlangen and Friedrich-Alexander-University (FAU) Erlangen-Nürnberg (Germany)
Christopher Fernandez-Prada, DVM, PhD
Affiliation: University of Montreal, McGill University, Chief of the Animal Parasitology Diagnostic Laboratory, Montreal (Canada)
Title: EV-driven genetic exchange in Leishmania as a novel mechanism of drug resistance in eukaryotic parasites.
Martin Olivier, PhD
Affiliation: The Research Institute of the McGill University Health Centre, Montréal (Canada)
Title: Leishmania Extracellular Vesicles: From Production to Cutaneous Leishmaniasis Development.
Ricardo Toshio Fujiwara, PhD
Affiliation: Federal University of Minas Gerais (Brazil)
Title: Development of new diagnostic test for the control of visceral leishmaniasis.
David Sacks, PhD
Affiliation: National Institutes of Health (USA)
Title: Sexual reproduction in Leishmania.
Albert Descoteaux, PhD
Affiliation: Centre INRS–Institut Armand-Frappier, Quebec (Canada)
Title: Host and parasite factors influencing host cell metabolism.
Gerald Spaeth, PhD
Affiliation: Institut Pasteur, Paris (France)
Title: Epistatic adaptation drives Leishmania fitness gain in culture and the field.
Phillip Scott, PhD
Affiliation: University of Pennsylvania (USA)
Title: Avaliable soon.
Anabela Cordeiro da Silva, PhD
Affiliation: i3S – Instituto de Investigação e Inovação em Saúde / IBMC – Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto (Portugal)
Title: Pre-clinical development of vaccines against leishmaniasis.
Title: Avaliable soon.
Susan Wyllie, PhD
Affiliation: School of Life Sciences, University of Dundee, Dundee (United Kingdom)
Dario S. Zamboni, PhD
Affiliation: University of São Paulo (Brazil)
Lars Gille, PhD
Affiliation: Department of Biomedical Sciences, University of Veterinary Medicine Vienna (Austria)
Title: Antileishmanial Activity of Synthetic Anthracene Endoperoxides: Efficiency and Mechanism.
Claudia M. d’Avila, PhD
Affiliation: Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro (Brazil)
Title: Monoxenous trypanosomatids in vertebrate hosts: facts or artifacts?
Hira Nakhasi, PhD
Affiliation: Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Research and Review, US Food and Drug Administration, Silver Spring (USA)
Title: Second generation leishmanization: using genetically modified dermotropic Leishmania as a pan Leishmania vaccine.
Gaetano Oliva, PhD
Affiliation: University of Naples Federico II (Italy)
Title: Canine leishmaniosis: preventative and therapeutic strategies to limit the dogs infectiousness.
Fabienne Tacchini-Cottier, PhD
Affiliation: University of Lausanne (Switzerland)
Title: The importance of neutrophils in cutaneous leishmaniasis.
Reuven Bergman, PhD
Affiliation: Rambam Health Care Campus (Israel)
Sergi Segarra, PhD
Affiliation: R&D Bioiberica SAU (Spain)
Title: Immunomodulation with dietary nucleotides in companion animals to optimize global prevention, treatment, and control strategies for leishmaniasis.
Vyacheslav Yurchenko, PhD
Affiliation: University of Ostrava (Czech Republic)
Title: Catalase is detrimental for Leishmania mexicana development and virulence.
Title: Avaliable soon.
- Canine leishmaniasis
- Feline leishmaniasis
- Human leishmaniasis
- Cutaneous leishmaniasis
- Visceral leishmaniasis
- Emerging treatments for leishmaniasis
- Immunotherapy in leishmaniasis
- New diagnostic approaches to leishmaniasis
- Emerging drugs, vaccines and therapies to fight leishmaniasis
- Leishmaniasis resistance to drugs
- Prevention strategies
- Leishmaniasis vectors biology and control
- New compounds against leishmaniasis
- Drug resistance and fitness in leishmania parasites
- Host parasite interaction
Hotel TRYP Lisboa Caparica Mar
Be aware of cold calls from Convention Hotel Services (CHS) or from someone named Adam Max! A company called CHS (Convention Hotel Services) is calling or e-mailing attendees of conferences worldwide, claiming to work for the conference organizers and asking for credit card details to finalize the booking of accommodation. If you receive such a call or e-mail, do not give away any personal information or credit card details! None of the parties involved in the organization of LEISHMANIASIS 2022 is working with CHS
We look forward to seeing you soon.
With kindest regards
The BIOSCOPE Team